- Home
- FNWD vs OBIO Comparison
FNWD vs OBIO Comparison
Compare FNWD & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- OBIO
- Stock Information
- Founded
- FNWD 1994
- OBIO 2017
- Country
- FNWD United States
- OBIO United States
- Employees
- FNWD N/A
- OBIO N/A
- Industry
- FNWD Savings Institutions
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- FNWD Finance
- OBIO Health Care
- Exchange
- FNWD Nasdaq
- OBIO Nasdaq
- Market Cap
- FNWD 141.1M
- OBIO 147.8M
- IPO Year
- FNWD N/A
- OBIO N/A
- Fundamental
- Price
- FNWD $32.41
- OBIO $2.69
- Analyst Decision
- FNWD Buy
- OBIO Strong Buy
- Analyst Count
- FNWD 1
- OBIO 4
- Target Price
- FNWD $34.00
- OBIO $14.00
- AVG Volume (30 Days)
- FNWD 37.0K
- OBIO 303.5K
- Earning Date
- FNWD 10-23-2025
- OBIO 08-12-2025
- Dividend Yield
- FNWD 1.47%
- OBIO N/A
- EPS Growth
- FNWD N/A
- OBIO N/A
- EPS
- FNWD 1.24
- OBIO N/A
- Revenue
- FNWD $63,780,000.00
- OBIO $2,944,000.00
- Revenue This Year
- FNWD N/A
- OBIO $19.83
- Revenue Next Year
- FNWD $7.77
- OBIO $12.53
- P/E Ratio
- FNWD $26.25
- OBIO N/A
- Revenue Growth
- FNWD N/A
- OBIO 41.61
- 52 Week Low
- FNWD $26.12
- OBIO $2.37
- 52 Week High
- FNWD $33.50
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- FNWD 72.09
- OBIO 48.29
- Support Level
- FNWD $31.29
- OBIO $2.65
- Resistance Level
- FNWD $32.63
- OBIO $2.79
- Average True Range (ATR)
- FNWD 0.75
- OBIO 0.16
- MACD
- FNWD 0.15
- OBIO 0.02
- Stochastic Oscillator
- FNWD 88.42
- OBIO 46.96
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.